Provectus Biopharmaceuticals, Inc. (PVCT)
OTCMKTS · Delayed Price · Currency is USD
0.0620
0.00 (0.00%)
Jun 16, 2026, 9:37 AM EST
PVCT Market Cap
PVCT has a market cap or net worth of $26.21 million as of June 16, 2026. Its market cap has decreased by -21.95% in one year.
Market Cap
26.21M
Enterprise Value
28.76M
Revenue
57.48K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.06
Market Cap Chart
Since April 24, 2002, PVCT's market cap has increased from 4.32K to 26.21M, an increase of 606,301.04%. That is a compound annual growth rate of 43.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 26.21M | 11.56% |
| Dec 31, 2025 | 23.49M | -53.46% |
| Dec 31, 2024 | 50.48M | 25.33% |
| Dec 29, 2023 | 40.27M | -11.35% |
| Dec 30, 2022 | 45.43M | 96.93% |
| Dec 31, 2021 | 23.07M | -1.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vicapsys Life Sciences | 47.26M |
| Nuo Therapeutics | 46.83M |
| EOM Pharmaceuticals Holdings | 25.30M |
| Arch Biopartners | 23.98M |
| NKGen Biotech | 19.59M |
| Anebulo Pharmaceuticals | 19.48M |
| Oncotelic Therapeutics | 17.74M |
| ZIVO Bioscience | 15.32M |